AU2002355665B2 — Particle cassette, method and kit therefor
Assigned to Powderject Research Ltd · Expires 2007-07-19 · 19y expired
What this patent protects
A particle cassette for a needleless syringe is provided, the manufacture of which avoids the potentially detrimental use of heat when affixing a final membrane to the cassette or otherwise sealing the cassette after a filling procedure has been carried out. The particle cassette…
USPTO Abstract
A particle cassette for a needleless syringe is provided, the manufacture of which avoids the potentially detrimental use of heat when affixing a final membrane to the cassette or otherwise sealing the cassette after a filling procedure has been carried out. The particle cassette is assembled using first and second cassette parts that are attachable together so as to create a chamber for the confinement of particles between two membranes. A third cassette part may be used to provide for a locking attachment of the first and second parts. A kit of parts for use in the manufacture of a particle cassette is also provided, as is a method of assembling a particle cassette. In certain cassette embodiments, one or both of the first and second cassette parts can be annular, tapered and/or have detents or recesses to provide for a snap fit.
Drugs covered by this patent
- Lignospan Forte (Lidocaine Hydrochloride) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.